EASE-CF: A study looking at a weight loss programme for people with CF
Details
- Therapeutic approach
- Nutritional-GI
- Trial status
- Open to recruitment Participating Centres
- Trials Tracker ID
- TT014826
- Last updated
- 11/12/2025
Weight loss intervention with specialist dietitian behavioural support for people with cystic fibrosis who have excess weight
Study detailsFour out of ten people with cystic fibrosis (CF) carry excess weight. It is thought that reducing excess weight is likely to be good for health in people with CF.
This research study will try to find out if it is safe and acceptable for people with CF to follow a programme with specialist CF dietitian support to help them lose excess weight.
Participants will be randomly placed into one of two groups.
The standard care group:
Participants will continue to attend their clinic appointments as normal and nothing about their care will change.
The intervention group:
Participants will be asked to eat three main meals per day:
- A high protein shake or porridge (provided for free)
- A fresh ready meal high in protein (provided for free)
- A self-selected healthy meal from a list of options provided that you will prepare or purchase
Participants in the intervention group will be provided weekly and then fortnightly support via short video calls with a specialist dietitian.
Participants from both groups will take part in four short assessments over video call. All participants will be sent equipment to record some simple measurements at home such as weight, lung function and blood pressure and asked to complete a remote blood testing kit which needs to be posted back.
All participants will also be asked to complete short online questionnaires and will be asked how they found out about this research study during an online interview.
- Phase
- Not applicable
- Length of participation
- 24 weeks
- Recruitment target
- 30
- CF sponsor
- University of Oxford
- CF sponsor type
- Academic
Who can take part?
- Age range
- 18 years and older
- Including people
- 18 years and older with a diagnosis of CF, including those who have previously received a lung or liver transplant
- FEV1 over 25% predicted
- BMI greater or equal to 27 Kg/m2
- Excluding people
- Who are pregnant, lactating or planning pregnancy during the course of the trial
- Currently participating in a structured weight loss programme or have experienced a self-reported weight loss of 10% in the 6 months before the screening visit
- Remote participation
- Remote participation is possible for this trial